- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07566273
Micropractices for Unhoused LGBTQ Youth
29 aprile 2026 aggiornato da: Cornell University
Developing and Evaluating Collaboratively Designed Mindfulness and Identity-Affirming Practices for Unhoused LGBTQ Youth
In the present study, the investigators will conduct a pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of brief, co-designed mindfulness and identity-affirming micropractices for LGBTQ youth and young adults experiencing housing instability.
Participants (n = 200, accounting for anticipated attrition) will be randomly assigned to one of two conditions: (1) a mindfulness and identity-based micropractice condition or (2) a structurally equivalent neutral control condition.
The intervention content will be developed using a participatory co-design process with members of the target population and standardized prior to trial implementation.
The mindfulness and identity condition integrates brief practices targeting present-moment awareness and identity affirmation, whereas the control condition accounts for time and attention without including these components.
Assessments will be conducted at baseline, post-intervention, and three-month follow-up.
Primary outcomes include feasibility and acceptability, assessed using standardized implementation outcome measures and indicators of intervention adherence.
Secondary outcomes include changes in mental health symptoms, psychological and emotional well-being, and substance use.
The investigators will evaluate whether the mindfulness and identity-based condition demonstrates greater improvements in outcomes compared to the control condition and will estimate effect sizes to inform the design of future fully powered trials.
The intervention will be delivered via a mobile-accessible platform.
Panoramica dello studio
Stato
Non ancora reclutamento
Condizioni
Descrizione dettagliata
Specific Aim 1: Evaluate the feasibility and acceptability of delivering co-designed mindfulness and identity-affirming micropractices to LGBTQ youth experiencing housing instability over a 30-day period.
Hypothesis 1: Participants in the mindfulness and identity-based condition will demonstrate higher adherence (e.g., daily completion rates) and report greater acceptability compared to the neutral control condition.
Specific Aim 2: Determine whether the mindfulness and identity-based micropractice condition, relative to the control condition, is associated with improvements in psychological and emotional well-being and reductions in distress and substance use.
Hypothesis 2: Participants in the mindfulness and identity-based condition will show greater increases in well-being and greater reductions in anxiety, depressive symptoms, and substance use from baseline to post-intervention and to three-month follow-up compared to the control condition.
Specific Aim 3: Assess whether engagement with the intervention (e.g., adherence to daily micropractices) is associated with improvements in psychosocial outcomes.
Hypothesis 3: Greater engagement with the mindfulness and identity-based micropractices will be associated with greater improvements in well-being and greater reductions in distress across the study period.
Exploratory Aim: Evaluate participants' experiences with the intervention, including perceived benefits, challenges, and contextual relevance of the micropractices.
This aim will be addressed through qualitative feedback collected during the study period.
The investigators will characterize common themes related to usability, relevance, and barriers to engagement, and will examine whether the intervention meets predefined criteria for feasibility and acceptability.
Tipo di studio
Interventistico
Iscrizione (Stimato)
200
Fase
- Prima fase 1
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
New York
-
New York, New York, Stati Uniti, 10018
- Ali Forney Center
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
Accetta volontari sani
Sì
Descrizione
Inclusion Criteria:
- Aged 16 to 26 years
- Self-identify as LGBTQ
- Currently or recently experiencing housing instability (within the past six months)
- Have access to a mobile device with internet capability to complete study activities
Exclusion Criteria:
- Unable to complete study procedures (e.g., lack of device access)
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Mindfulness and Identity Condition
Participants will be assigned to complete a brief daily micropractice that integrates mindfulness (e.g., attention to breathing or present-moment awareness) with reflection on personally meaningful aspects of identity.
The micropractice is delivered via a mobile-accessible platform over a 30-day period.
|
Participants will complete a brief daily micropractice (approximately 1-5 minutes per day) that integrates mindfulness (e.g., attention to breathing or present-moment awareness) with reflection on personally meaningful aspects of identity.
The micropractice is co-designed with members of the target population, standardized prior to the trial, and delivered via a mobile-accessible platform.
|
|
Comparatore attivo: Control Condition
Participants will be assigned to complete a brief daily activity matched in structure, duration, and delivery format, but without mindfulness or identity-based content.
Activities focus on neutral reflections (e.g., daily routines or surroundings) and are delivered via a mobile-accessible platform over a 30-day period.
|
Participants will complete a brief daily activity (approximately 1-5 minutes per day) matched in structure and delivery format to the intervention condition, but without mindfulness or identity-based content.
Activities include neutral reflections (e.g., daily routines or surroundings) and are delivered via a mobile-accessible platform.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Acceptability (Acceptability of Intervention Measure [AIM])
Lasso di tempo: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using four items measuring participant-reported implementation outcome items evaluating approval, liking, and overall acceptance of the assigned activity.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater acceptability.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Appropriateness (Intervention Appropriateness Measure [IAM])
Lasso di tempo: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using four items measuring participant-reported implementation outcome items evaluating whether the assigned activity seems relevant, fitting, and compatible with participants' lives.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater appropriateness.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Feasibility (Feasibility of Intervention Measure [FIM])
Lasso di tempo: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using four items measuring participant-reported implementation outcome items evaluating whether the assigned activity seems workable, possible, and easy to do in daily life.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater feasibility.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Intervention adherence
Lasso di tempo: Assessed daily during the 30-day intervention period.
|
Assessed by self-reported completion of the assigned daily activity during the 30-day intervention period.
Higher adherence indicates a better outcome.
|
Assessed daily during the 30-day intervention period.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Purpose in Life (Life Engagement Test [LET])
Lasso di tempo: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 6 items measuring the extent to which participants experience purpose, meaning, and value in their daily activities.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater purpose.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Depressive Symptoms (Center for Epidemiologic Studies Depression Scale [CES-D])
Lasso di tempo: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 10 items measuring depressive symptoms during the past week.
Responses are given on a 4-point Likert scale.
Higher scores indicate greater depressive symptoms.
Lower scores indicate a better outcome.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Anxiety Symptoms (Generalized Anxiety Disorder-7 Scale [GAD-7])
Lasso di tempo: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 7 items measuring anxiety symptoms over the last 2 weeks.
Responses are given on a 4-point Likert scale.
Higher scores indicate greater anxiety symptoms.
Lower scores indicate a better outcome.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Psychological, emotional, and social well-being (Mental Health Continuum- Short Form [MHC-SF])
Lasso di tempo: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 14 items measuring emotional, psychological, and social well-being during the past month.
Responses are given on a 6-point Likert scale.
Higher scores indicate greater well-being.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Self-Esteem (Rosenberg Self-Esteem Scale [RSE])
Lasso di tempo: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 10 items measuring global self-esteem over the past 30 days.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater self-esteem.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Authenticity (Authenticity Scale)
Lasso di tempo: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Includes two dimensions of the Authenticity Scale: Self-Alienation and Authentic Living.
Self-Alienation is assessed using 4 items measuring participants' sense of being out of touch with the "real me".
Higher scores indicate lower authenticity.
Authentic Living is assessed using 4 items measuring participants' sense of being true to themselves, their beliefs, and values.
Higher scores indicate greater authenticity.
Responses are given on a 7-point Likert scale.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
|
Substance Use Risk (CRAFFT Screening Test)
Lasso di tempo: Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Assessed using 11 items measuring likelihood of alcohol- and drug-related risk behaviors over the past 30 days.
Responses are given on a 5-point Likert scale.
Higher scores indicate greater substance use risk.
Lower scores indicate a better outcome.
|
Change from baseline to post-intervention (30 days), and to 3-month follow-up.
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Likelihood of recommending the assigned activity to a friend
Lasso di tempo: Assessed at post-intervention (30 days) and 3-month follow-up.
|
Assessed using a single item asking how likely participants are to recommend the assigned activity to a friend, rated from 0 to 10. Higher scores indicate greater willingness to recommend the activity.
|
Assessed at post-intervention (30 days) and 3-month follow-up.
|
|
Participant feedback on barriers and overall experience
Lasso di tempo: Assessed during the 30-day intervention period.
|
Assessed using open-ended items asking participants about reasons for not completing daily activities, comments about the study, and perceived benefits or challenges related to participation.
Responses will be analyzed qualitatively.
|
Assessed during the 30-day intervention period.
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Collaboratori
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
1 ottobre 2026
Completamento primario (Stimato)
1 novembre 2026
Completamento dello studio (Stimato)
1 gennaio 2027
Date di iscrizione allo studio
Primo inviato
29 aprile 2026
Primo inviato che soddisfa i criteri di controllo qualità
29 aprile 2026
Primo Inserito (Effettivo)
5 maggio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
5 maggio 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
29 aprile 2026
Ultimo verificato
1 aprile 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- IRB0150559
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
INDECISO
Descrizione del piano IPD
As this study involves community-based work with a marginalized population, we want to ensure that researchers accurately represent the population in future research.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Mindfulness and Identity-Based Micropractice
-
Indiana UniversityCompletato
-
Oregon Health and Science UniversityJohn & Tami Marick FoundationNon ancora reclutamentoDepressione perinatale
-
University of MiamiUnited States Department of DefenseTerminato
-
Walter Reed Army Institute of Research (WRAIR)U.S. Army Medical Research and Development Command; U.S. Army Training and Doctrine...CompletatoDolore | Fatica | Salute, Soggettiva | Sonno | Ansia | Sintomi depressivi | Stato d'animo | Comando | Regolazione delle emozioni | Yoga | Consapevolezza | Lesione muscoloscheletrica | Operazioni militari | Coesione, socialeStati Uniti
-
Hacettepe UniversityCompletatoDiabete di tipo 2Tacchino
-
Royal College of Surgeons, IrelandAttivo, non reclutanteBruciato | Consapevolezza | Stress (Psicologia)Irlanda
-
Sam Houston State UniversityTerminato
-
Universidad Pontificia de SalamancaMinisterio de Ciencia e Innovación, SpainCompletatoRisposta infiammatoria | Benessere | Salute mentale | Consapevolezza | Salute cardiovascolare | Auto compassioneSpagna
-
Eric LoucksSconosciutoAttività fisica | Stress, Psicologico | Sonno | Sintomi depressivi | Dieta | Comportamento sedentario | Solitudine | Regolazione emotiva | Consapevolezza | Consumo di alcol, giovaniStati Uniti
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA)Completato